Analysis of local expression of inflammatory cytokines genes in patients with gastroesophageal reflux disease and its association with types and number of gastroesophageal refluxes

The aim of the study was to evaluate gene expression of proinflammatory cytokines in esophageal mucosa in patients with erosive esophagitis (EE) and non-erosive form (NERD) of gastroesophageal reflux disease (GERD) and perform correlation analysis between the genes expression and types and number of gastroesophageal refluxes. Methods. This was a single-center prospective study. Esophageal mucosa samples were taken from lower part of the esophagus during endoscopy. Expression of IL-1b, IL-10, IL-18, TNFA, TLR4, GATA3, CD68 and beta-2 macroglobulin genes was assessed with ImmunoQuantex assays. Multichannel intraluminal esophageal pH-impedance studies were performed with Ohmega recorder and 2pH-6impedance catheters. Results. Data of 60 patients (females - 34; mean age (M±SD) 54.6 years, 20 - with erosive esophagitis) were available for the analysis. In those with EE, there was higher expression of IL-18 (5.89±0.4 vs 5.28±1.1, p=0.04), GATA3 (2.92±0.86 vs 2.23±0.96, p=0.03) genes, and inflammatory index (92.12±32.41% vs 70.1±30.8%, p=0.02) compared to NERD. Direct correlation was found between acid exposure time and expression of IL-1b (Spearman rank R = 0.29), IL-18 (R=0.31), TNFA (R=0.35), GATA3 (R=0.34), TLR4 (R=0.29), CD68 (R=0.37) genes and inflammatory index (R=0.3). Indirect correlation was revealed between mean рН and expressions of IL-18 (R= -0.28), TNFA (R= -0.33), GATA3 (R= -0.28), TLR4 (R= -0.28), CD68 (R= -0.39) genes and inflammatory index (R= -0.17). No correlation was found between the genes’ expression and number of gastroesophageal refluxes. Conclusions: Expression of proinflammatory cytokines’ genes differ in patients with EE and NERD. There is a correlation between expression of studied genes and esophageal acidity.

gastroesophageal reflux, gastroesophageal reflux disease, GERD, interleukins, gene expression, multichannel intraluminal pH-impedance

1. Ivashkin V.T., Maev I. V., Trukhmanov A. S., et al. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(4):70-97. (In Russ.) doi: 10.22416/1382-4376-2020-30-4-70-97 @@Ивашкин В. Т., Маев И. В., Трухманов А. С., и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020;30(4):70-97. doi: 10.22416/1382-4376-2020-30-4-70-97

2. Vakil N. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900-1920.

3. Lundell L. R., Dent J., Bennett J. R., et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172-80. doi: 10.1136/gut.45.2.172

4. Kasyap A. K., Sah S. K., Chaudhary S. Clinical spectrum and risk factors associated with asymptomatic erosive esophagitis as determined by Los Angeles classification: A crosssectional study. PLoS One. 2018;13(2): e0192739

5. Knowles C. H., Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut. 2008;57(5):674-683.

6. Savarino E., Tutuian R., Zentilin P., et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol. 2010;105(5):1053-1061.

7. Ronkainen J., Talley N. J., Storskrubb T., et al. Erosive esophagitis is a risk factor for Barrett’s esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol. 2011;106(11):1946-1952.

8. Katzka D. A., Pandolfino J. E., Kahrilas P. J. Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. Clinical Gastroenterology and Hepatology. 2020;18:767-776. doi: 10.1016/j.cgh.2019.07.015

9. Yamaguchi T., Yoshida N., Tomatsuri N., et al. Cytokine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats.Int J Mol Med. 2005;16(1):71-77.

10. Hamaguchi M., Fujiwara Y., Takashima T., et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion. 2003;68(4):189-197.

11. Isomoto H., Saenko V. A., Kanazawa Y., et al. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy- negative gastroesophageal reflux disease. Am J Gastroenterol. 2004;99(4):589-597.

12. Souza R. F., Huo X., Mittal V., et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137(5):1776-1784.

13. Morozov S. V. GERD-Q questionnaire - a novel tool for gastroesophageal reflux disease diagnosis. Akademicheskij Zhurnal Zapadnoj Sibiri. 2014; 3 (52): 26-28. (In Russ.) @@Морозов С. В. Опросник GERD-Q - новый инструмент диагностики гастроэзофагеальной рефлюксной болезни для врача общей практики. Академический журнал Западной Сибири. 2014; 3 (52): 26-28.

14. Roman S., Gyawali C. P., Savarino E., Yadlapati R., Zerbib F., Wu J., Vela M., Tutuian R., Tatum R., Sifrim D., Keller J., Fox M., Pandolfino J. E., Bredenoord A. J.; GERD consensus group. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29(10):1-15. doi: 10.1111/nmo.13067.

15. Kozlov I. B., Vatazin A. V., Kildushevsky A. V., et al. Analysis of expression of immune system genes that are responsible for activation and inhibition of T-cell immune response in renal transplant recipients after extracorporeal photochemotherapy. Immunologiya. 2020; 41 (1): 20-30. (in Russ.) doi: 10.33029/0206-4952-2020-41-1-20-30 @@Козлов И. Б., Ватазин А. В., Кильдюшевский А. В., и др. Анализ экспрессии генов иммунной системы, ответственных за активацию и ингибирование Т-клеточного иммунного ответа, у реципиентов почечного трансплантата после ЭКФ. Иммунология. 2020; 41 (1): 20-30. doi: 10.33029/0206-4952-2020-41-1-20-30

16. Katkova N. Yu., Bodrikova O. I., Sergeeva A. V., Bezrukova I. M., Pokusaeva K. B. The local immune profile of the woman and different scenarios of preterm delivery. Bulletin of RSMU. 2017; (3): 53-7. (in Russ.) doi: 10.24075/brsmu.2017-03-07 @@Каткова Н. Ю., Бодрикова О. И., Сергеева А. В., Безрукова И. М., Покусаева К. Б. Состояние локального иммунного статуса при различных вариантах преждевременных родов. Вестник РГМУ. 2017;3:57-62. doi: 10.24075/brsmu.2017-03-07

17. https://patenton.ru/patent/RU2552310C2 World Wide Web document. Accessed 05.11.2021.

18. Yevsyutina Yu. V., Trukhmanov A. S., Ivashkin V. T., Lyamina S. V., Malyshev I. Yu. Systemic immune response at gastroesophageal reflux disease.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015; 25(5):32-38. (in Russ.) @@Евсютина Ю. В., Трухманов А. С., Ивашкин В. Т., Лямина С. В., Малышев И. Ю. Системный иммунный ответ у пациентов с гастроэзофагеальной рефлюксной болезнью. РЖГГК. 2015; 5:32-38.

19. Isomoto H, Inoue K, Kohno S.Interleukin-8 levels in esophageal mucosa and long-term clinical outcome of patients with reflux esophagitis. Scand J Gastroenterol. 2007;42(3):410-411. doi:10.1080/00365520600931469

20. Zhong Y. Q., Lin Y., Xu Z. Expression of IFN-γ and IL-4 in the esophageal mucosa of patients with reflux esophagitis and Barrett’s esophagus and their relationship with endoscopic and histologic grading. Dig Dis Sci. 2011;56(10):2865-2870. doi:10.1007/s10620-011-1696-9

21. Mönkemüller K., Wex T., Kuester D., et al.Interleukin-1beta and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients with erosive and non-erosive reflux disease. Digestion. 2009;79(3):186-195. doi:10.1159/000211714

22. Zavala-Solares M.R., Fonseca-Camarillo G., Valdovinos M., et al. Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study. BMC Gastroenterol. 2021;21(1):201. Published 2021 May 3. doi:10.1186/s12876-021-01707-7

23. Wang C., Hunt R. H. Precise role of acid in non-erosive reflux disease. Digestion. 2008;78 Suppl 1:31-41. doi:10.1159/000151253

24. Belova O.V, Arion V. O., Sergienko V. I. The role of cytokines in immunological function of skin. Immunopatologija, allergologija, infektologija. 2008; 1: 41-55. (in Russ.) @@Белова О.В, Арион В. О., Сергиенко В. И. Роль цитокинов в иммунологической функции кожи. Иммунопатология, аллергология, инфектология. 2008; 1: 41-55.

25. Christodoulou C, Choy EH. Joint inflammation and cytokine inhibition in rheumatoid arthritis. Clin Exp Med. 2006;6(1):13-19. doi:10.1007/s10238-006-0088-5

26. Glotov A. V., Potudanskaya M. G., ed. Fundamentals of Immunology, Immunogenetics and immunobiotechnology: Textbook. Omsk: Omsk State Univ.: 2009. (in Russ.) @@Глотов А. В., Потуданская М. Г., ред. Основы иммунологии, иммуногенетики и иммунобиотехнологии. Учеб. пособие. Омск: Омский гос. ун-т; 2009. 119 с.

27. Chistiakov D. A., Killingsworth M. C., Myasoedova V. A., Orekhov A. N., Bobryshev Y. V. CD68/macrosialin: not just a histochemical marker. Lab Invest. 2017;97(1):4-13. doi:10.1038/labinvest.2016.116

28. Stashkevich D. S., Filippova Yu. Yu., Burmistrova A. L., ed. Actual matters of immunology: system of cytokines, biological value, genetic polymorphism, methods of detection: Textbook. Chelyabinsk: Tsitsero; 2016. (in Russ.) @@Сташкевич Д. С., Филиппова Ю. Ю., Бурмистрова А. Л., ред. Актуальные вопросы иммунологии: система цитокинов, биологическое значение, генетический полиморфизм, методы определения. Учебное пособие. Челябинск: Цицеро; 2016. 82 с.

29. Hamaguchi M., Fujiwara Y., Takashima T., et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion. 2003;68(4):189-197. doi:10.1159/000075698

30. Barnes P. J. Targeting cytokines to treat asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2018;18(7):454-466. doi:10.1038/s41577-018-0006-6

31. Bachert C., Zhang L., Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis. J Allergy Clin Immunol. 2015;136(6):1431-1440. doi:10.1016/j.jaci.2015.10.010

32. Molina-Infante J., Gonzalez-Cordero P.L., Lucendo A. J. Proton pump inhibitor-responsive esophageal eosinophilia: still a valid diagnosis? Curr Opin Gastroenterol. 2017 Jul;33(4):285-292. doi: 10.1097/MOG.0000000000000371.